Cardioprotective effect of sevoflurane in patients with coronary artery disease undergoing vascular surgery
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Medknow in Saudi Journal of Anaesthesia
- Vol. 6 (2) , 125-30
Abstract
Objectives: The present study was conducted to evaluate the cardioprotective effect of sevoflurane compared with propofol in patients with coronary artery disease (CAD) undergoing peripheral vascular surgery; and to address the question whether a volatile anesthetic might improve cardiac outcome in these patients. Methods: One hundred twenty-six patients scheduled for elective peripheral vascular surgery were prospectively randomized to receive either sevoflurane inhalation anesthesia or total intravenous anesthesia. ST-segment monitoring was performed continuously during intra- and post-operative 48 h periods. The number of ischemic events and the cumulative duration of ischemia in each patient were recorded. Blood was sampled in all patients for the determination of cTnI. Samples were obtained before the induction of anesthesia, on admission to the ICU, and at 6, 12, 24, and 48 h after admission to the intensive care unit (ICU). Patients were followed-up during their hospital stay for any adverse cardiac events. Results: The incidence of ischemia were comparable among the groups [16 (25%) patients in sevoflurane group vs 24 (39%) patients in propofol group; P=0.126]. Duration, cumulative duration, and magnitude of ST-segment depression of ischemic events in each patient were significantly less in sevoflurane group (P=0.008, 0.048, 0.038, respectively). cTnI levels of the overall population were significantly less in sevoflurane group vs propofol group (P values P<0.0001, <0.0001, <0.0001, 0.0003). None of the patients presented with unstable angina, myocardial infarction, congestive heart failure, or serious arrhythmia either during ICU or hospital stay. Conclusion: Patients with CAD receiving sevoflurane for peripheral vascular surgery had significantly lower release of cardiac troponin I at 6 h postoperatively and lasting for 48 h than patients receiving propofol for the same procedure with significant decrease in duration, cumulative duration of ischemic events, and degree of ST depression in each patient.Keywords
This publication has 21 references indexed in Scilit:
- Volatile Agents for Cardiac Protection in Noncardiac Surgery: A Randomized Controlled StudyJournal of Cardiothoracic and Vascular Anesthesia, 2011
- Cardioprotection by Volatile Anesthetics: What About Noncardiac Surgery?Journal of Cardiothoracic and Vascular Anesthesia, 2011
- Perioperative Cardiac Damage in Vascular Surgery PatientsEuropean Journal of Vascular and Endovascular Surgery, 2010
- Universal Definition of Myocardial InfarctionCirculation, 2007
- ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac SurgeryJACC, 2007
- Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy IndividualsJACC, 2007
- Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevationEuropean Heart Journal, 2005
- Automated Electrocardiograph ST Segment Trending MonitorsAnesthesia & Analgesia, 1998
- Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgeryThe Lancet, 1993
- Long-term prognosis of myocardial ischemia detected by holter monitoring in peripheral vascular diseaseThe American Journal of Cardiology, 1990